{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:10:02Z","timestamp":1793747402372,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81922008"],"award-info":[{"award-number":["81922008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070398"],"award-info":[{"award-number":["82070398"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Microvascular complications are associated with an overtly increased risk of adverse outcomes in patients with diabetes including coronary microvascular injury which manifested as disruption of adherens junctions between cardiac microvascular endothelial cells (CMECs). However, particular mechanism leading to diabetic coronary microvascular hyperpermeability remains elusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Experimental diabetes was induced in mice with adipose tissue-specific Adipsin overexpression (Adipsin\n                      <jats:sup>LSL\/LSL<\/jats:sup>\n                      -Cre) and their respective control (Adipsin\n                      <jats:sup>LSL\/LSL<\/jats:sup>\n                      ). In addition, cultured CMECs were subjected to high glucose\/palmitic acid (HG + PA) treatment to simulate diabetes for a mechanistic approach.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results showed that Adipsin overexpression significantly reduced cardiac microvascular permeability, preserved coronary microvascular integrity, and increased coronary microvascular density. Adipsin overexpression also attenuated cardiac dysfunction in diabetic mice. E\/A ratio, an indicator of cardiac diastolic function, was improved by Adipsin. Adipsin overexpression retarded left ventricular adverse remodeling, enhanced LVEF, and improved cardiac systolic function. Adipsin-enriched exosomes were taken up by CMECs, inhibited CMECs apoptosis, and increased CMECs proliferation under HG + PA treatment. Adipsin-enriched exosomes also accelerated wound healing, rescued cell migration defects, and promoted tube formation in response to HG + PA challenge. Furthermore, Adipsin-enriched exosomes maintained adherens junctions at endothelial cell borders and reversed endothelial hyperpermeability disrupted by HG + PA insult. Mechanistically, Adipsin blocked HG + PA-induced Src phosphorylation (Tyr416), VE-cadherin phosphorylation (Tyr685 and Tyr731), and VE-cadherin internalization, thus maintaining CMECs adherens junctions integrity. LC-MS\/MS analysis and co-immunoprecipitation analysis (Co-IP) unveiled Csk as a direct downstream regulator of Adipsin. Csk knockdown increased Src phosphorylation (Tyr416) and VE-cadherin phosphorylation (Tyr685 and Tyr731), while abolishing Adipsin-induced inhibition of VE-cadherin internalization. Furthermore, Csk knockdown counteracted Adipsin-induced protective effects on endothelial hyperpermeability in vitro and endothelial barrier integrity of coronary microvessels in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Together, these findings favor the vital role of Adipsin in the regulation of CMECs adherens junctions integrity, revealing its promises as a treatment target against diabetic coronary microvascular dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                    <jats:p>Graphical abstract depicting the mechanisms of action behind Adipsin-induced regulation of diabetic coronary microvascular dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-023-02887-7","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T14:02:13Z","timestamp":1685109733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Adipsin alleviates cardiac microvascular injury in diabetic cardiomyopathy through Csk-dependent signaling mechanism"],"prefix":"10.1186","volume":"21","author":[{"given":"Xuebin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanrong","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2147-3977","authenticated-orcid":false,"given":"Dongdong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"2887_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","volume":"128","author":"K Ogurtsova","year":"2017","unstructured":"Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40\u201350. https:\/\/doi.org\/10.1016\/j.diabres.2017.03.024.","journal-title":"Diabetes Res Clin Pract."},{"issue":"9733","key":"2887_CR2","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(10)60484-9.","journal-title":"Lancet."},{"issue":"11","key":"2887_CR3","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/ejhf.1201","volume":"20","author":"SL Kristensen","year":"2018","unstructured":"Kristensen SL, R\u00f8rth R, Jhund PS, Shen L, Lee M, Petrie MC, et al. Microvascular complications in diabetes patients with heart failure and reduced ejection fraction-insights from the Beta-blocker evaluation of survival trial. Eur J Heart Fail. 2018;20(11):1549\u201356. https:\/\/doi.org\/10.1002\/ejhf.1201.","journal-title":"Eur J Heart Fail."},{"issue":"1","key":"2887_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2337\/dc11-1380","volume":"35","author":"A Solini","year":"2012","unstructured":"Solini A, Penno G, Bonora E, Fondelli C, Orsi E, Arosio M, et al. Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Diabetes Care. 2012;35(1):143\u20139. https:\/\/doi.org\/10.2337\/dc11-1380.","journal-title":"Diabetes Care."},{"issue":"9","key":"2887_CR5","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1055\/s-0043-120570","volume":"126","author":"M Voigt","year":"2018","unstructured":"Voigt M, Schmidt S, Lehmann T, K\u00f6hler B, Kloos C, Voigt UA, et al. Prevalence and progression rate of diabetic retinopathy in type 2 diabetes patients in correlation with the duration of diabetes. Exp Clin Endocrinol Diabetes. 2018;126(9):570\u20136. https:\/\/doi.org\/10.1055\/s-0043-120570.","journal-title":"Exp Clin Endocrinol Diabetes."},{"issue":"8","key":"2887_CR6","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.jdiacomp.2015.06.014","volume":"29","author":"L Salvotelli","year":"2015","unstructured":"Salvotelli L, Stoico V, Perrone F, Cacciatori V, Negri C, Brangani C, et al. Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: the verona diabetic foot screening program. J Diabetes Complications. 2015;29(8):1066\u201370. https:\/\/doi.org\/10.1016\/j.jdiacomp.2015.06.014.","journal-title":"J Diabetes Complications."},{"issue":"4","key":"2887_CR7","doi-asserted-by":"publisher","first-page":"960","DOI":"10.2337\/dc10-1945","volume":"34","author":"E Selvin","year":"2011","unstructured":"Selvin E, Francis LM, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL, et al. Nontraditional markers of glycemia: associations with microvascular conditions. Diabetes Care. 2011;34(4):960\u20137. https:\/\/doi.org\/10.2337\/dc10-1945.","journal-title":"Diabetes Care."},{"issue":"8","key":"2887_CR8","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/s0735-1097(03)00166-9","volume":"41","author":"MF Di Carli","year":"2003","unstructured":"Di Carli MF, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol. 2003;41(8):1387\u201393. https:\/\/doi.org\/10.1016\/s0735-1097(03)00166-9.","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"2887_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2796.2007.01830.x","volume":"262","author":"PA Jansson","year":"2007","unstructured":"Jansson PA. Endothelial dysfunction in insulin resistance and type 2 diabetes. J Intern Med. 2007;262(2):173\u201383. https:\/\/doi.org\/10.1111\/j.1365-2796.2007.01830.x.","journal-title":"J Intern Med."},{"key":"2887_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijcard.2019.02.030","volume":"291","author":"A Avogaro","year":"2019","unstructured":"Avogaro A, Fadini GP. Microvascular complications in diabetes: A growing concern for cardiologists. Int J Cardiol. 2019;291:29\u201335. https:\/\/doi.org\/10.1016\/j.ijcard.2019.02.030.","journal-title":"Int J Cardiol."},{"issue":"2","key":"2887_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85\u201397. https:\/\/doi.org\/10.1038\/nri2921.","journal-title":"Nat Rev Immunol."},{"issue":"1","key":"2887_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cell.2014.06.005","volume":"158","author":"JC Lo","year":"2014","unstructured":"Lo JC, Ljubicic S, Leibiger B, Kern M, Leibiger IB, Moede T, et al. Adipsin is an adipokine that improves \u03b2 cell function in diabetes. Cell. 2014;158(1):41\u201353. https:\/\/doi.org\/10.1016\/j.cell.2014.06.005.","journal-title":"Cell."},{"issue":"19","key":"2887_CR13","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1073\/pnas.82.19.6480","volume":"82","author":"KS Cook","year":"1985","unstructured":"Cook KS, Groves DL, Min HY, Spiegelman BM. A developmentally regulated mRNA from 3T3 adipocytes encodes a novel serine protease homologue. Proc Natl Acad Sci U S A. 1985;82(19):6480\u20134. https:\/\/doi.org\/10.1073\/pnas.82.19.6480.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4813","key":"2887_CR14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1126\/science.3299705","volume":"237","author":"KS Cook","year":"1987","unstructured":"Cook KS, Min HY, Johnson D, Chaplinsky RJ, Flier JS, Hunt CR, et al. Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science. 1987;237(4813):402\u20135. https:\/\/doi.org\/10.1126\/science.3299705.","journal-title":"Science."},{"issue":"4813","key":"2887_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.3299706","volume":"237","author":"JS Flier","year":"1987","unstructured":"Flier JS, Cook KS, Usher P, Spiegelman BM. Severely impaired adipsin expression in genetic and acquired obesity. Science. 1987;237(4813):405\u20138. https:\/\/doi.org\/10.1126\/science.3299706.","journal-title":"Science."},{"issue":"11","key":"2887_CR16","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s41591-019-0610-4","volume":"25","author":"N G\u00f3mez-Banoy","year":"2019","unstructured":"G\u00f3mez-Banoy N, Guseh JS, Li G, Rubio-Navarro A, Chen T, Poirier B, et al. Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans. Nat Med. 2019;25(11):1739\u201347. https:\/\/doi.org\/10.1038\/s41591-019-0610-4.","journal-title":"Nat Med."},{"issue":"1","key":"2887_CR17","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41467-023-36680-0","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Han S, Liu C, Zheng Y, Li H, Gao F, et al. THADA inhibition in mice protects against type 2 diabetes mellitus by improving pancreatic \u03b2-cell function and preserving \u03b2-cell mass. Nat Commun. 2023;14(1):1020. https:\/\/doi.org\/10.1038\/s41467-023-36680-0.","journal-title":"Nat Commun."},{"key":"2887_CR18","doi-asserted-by":"publisher","unstructured":"Gao P, Li L, Yang L, Gui D, Zhang J, Han J, et al. Yin Yang 1 protein ameliorates diabetic nephropathy pathology through transcriptional repression of TGF\u03b21. Sci Transl Med. 2019;11(510). https:\/\/doi.org\/10.1126\/scitranslmed.aaw2050.","DOI":"10.1126\/scitranslmed.aaw2050"},{"issue":"17","key":"2887_CR19","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.7150\/thno.77043","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Cao Y, Zheng R, Xiong Z, Zhu Z, Gao F, et al. Fibroblast-specific activation of Rnd3 protects against cardiac remodeling in diabetic cardiomyopathy via suppression of Notch and TGF-\u03b2 signaling. Theranostics. 2022;12(17):7250\u201366. https:\/\/doi.org\/10.7150\/thno.77043.","journal-title":"Theranostics."},{"issue":"12","key":"2887_CR20","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1161\/CIRCRESAHA.110.223925","volume":"107","author":"E Gao","year":"2010","unstructured":"Gao E, Lei YH, Shang X, Huang ZM, Zuo L, Boucher M, et al. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res. 2010;107(12):1445\u201353. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.223925.","journal-title":"Circ Res."},{"issue":"6","key":"2887_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00395-020-00835-7","volume":"115","author":"M Dia","year":"2020","unstructured":"Dia M, Gomez L, Thibault H, Tessier N, Leon C, Chouabe C, et al. Reduced reticulum-mitochondria Ca(2+) transfer is an early and reversible trigger of mitochondrial dysfunctions in diabetic cardiomyopathy. Basic Res Cardiol. 2020;115(6):74. https:\/\/doi.org\/10.1007\/s00395-020-00835-7.","journal-title":"Basic Res Cardiol."},{"key":"2887_CR22","doi-asserted-by":"publisher","unstructured":"Gupta D, Zickler AM, El Andaloussi S. Dosing extracellular vesicles. Adv Drug Deliv Rev. 2021;178:113961. https:\/\/doi.org\/10.1016\/j.addr.2021.113961.","DOI":"10.1016\/j.addr.2021.113961"},{"key":"2887_CR23","doi-asserted-by":"publisher","first-page":"34199","DOI":"10.1038\/srep34199","volume":"6","author":"J Lin","year":"2016","unstructured":"Lin J, Zhang L, Zhang M, Hu J, Wang T, Duan Y, et al. Mst1 inhibits CMECs autophagy and participates in the development of diabetic coronary microvascular dysfunction. Sci Rep. 2016;6:34199. https:\/\/doi.org\/10.1038\/srep34199.","journal-title":"Sci Rep."},{"issue":"5","key":"2887_CR24","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.2337\/db12-1025","volume":"62","author":"D Wang","year":"2013","unstructured":"Wang D, Luo P, Wang Y, Li W, Wang C, Sun D, et al. Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP\/PKA\/Rho-dependent mechanism. Diabetes. 2013;62(5):1697\u2013708. https:\/\/doi.org\/10.2337\/db12-1025.","journal-title":"Diabetes."},{"key":"2887_CR25","doi-asserted-by":"publisher","unstructured":"Witwer KW, Goberdhan DC, O'Driscoll L, Th\u00e9ry C, Welsh JA, Blenkiron C, et al. Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles. J Extracell Vesicles. 2021;10(14):e12182. https:\/\/doi.org\/10.1002\/jev2.12182.","DOI":"10.1002\/jev2.12182"},{"key":"2887_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/7651_2020_309","volume":"2367","author":"MS Adil","year":"2021","unstructured":"Adil MS, Somanath PR. Endothelial permeability assays in vitro. Methods Mol Biol. 2021;2367:177\u201391. https:\/\/doi.org\/10.1007\/7651_2020_309.","journal-title":"Methods Mol Biol."},{"issue":"13","key":"2887_CR27","doi-asserted-by":"publisher","first-page":"8199","DOI":"10.1167\/iovs.15-17098","volume":"56","author":"A Rabiolo","year":"2015","unstructured":"Rabiolo A, Bignami F, Rama P, Ferrari G. VesselJ: a new tool for semiautomatic measurement of corneal neovascularization. Invest Ophthalmol Vis Sci. 2015;56(13):8199\u2013206. https:\/\/doi.org\/10.1167\/iovs.15-17098.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"2887_CR28","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/ncomms2199","volume":"3","author":"F Orsenigo","year":"2012","unstructured":"Orsenigo F, Giampietro C, Ferrari A, Corada M, Galaup A, Sigismund S, et al. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun. 2012;3:1208. https:\/\/doi.org\/10.1038\/ncomms2199.","journal-title":"Nat Commun."},{"issue":"1","key":"2887_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cell.2008.05.051","volume":"134","author":"NM Levinson","year":"2008","unstructured":"Levinson NM, Seeliger MA, Cole PA, Kuriyan J. Structural basis for the recognition of c-Src by its inactivator Csk. Cell. 2008;134(1):124\u201334. https:\/\/doi.org\/10.1016\/j.cell.2008.05.051.","journal-title":"Cell."},{"key":"2887_CR30","doi-asserted-by":"publisher","unstructured":"Duan Y, Zhang X, Zhang X, Lin J, Shu X, Man W, et al. Inhibition of macrophage-derived foam cells by Adipsin attenuates progression of atherosclerosis. Biochim Biophys Acta Mol Basis Dis. 2022;1868(12):166533. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166533.","DOI":"10.1016\/j.bbadis.2022.166533"},{"key":"2887_CR31","doi-asserted-by":"publisher","first-page":"1003282","DOI":"10.3389\/fcvm.2022.1003282","volume":"9","author":"W Man","year":"2022","unstructured":"Man W, Song X, Xiong Z, Gu J, Lin J, Gu X, et al. Exosomes derived from pericardial adipose tissues attenuate cardiac remodeling following myocardial infarction by Adipsin-regulated iron homeostasis. Front Cardiovasc Med. 2022;9:1003282. https:\/\/doi.org\/10.3389\/fcvm.2022.1003282.","journal-title":"Front Cardiovasc Med."},{"issue":"4","key":"2887_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213\u201328. https:\/\/doi.org\/10.1038\/nrm.2017.125.","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"10","key":"2887_CR33","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMra1704286","volume":"379","author":"R Shah","year":"2018","unstructured":"Shah R, Patel T, Freedman JE. Circulating extracellular vesicles in human disease. N Engl J Med. 2018;379(10):958\u201366. https:\/\/doi.org\/10.1056\/NEJMra1704286.","journal-title":"N Engl J Med."},{"issue":"10","key":"2887_CR34","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1172\/JCI129187","volume":"129","author":"CR Kahn","year":"2019","unstructured":"Kahn CR, Wang G, Lee KY. Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. J Clin Invest. 2019;129(10):3990\u20134000. https:\/\/doi.org\/10.1172\/JCI129187.","journal-title":"J Clin Invest."},{"issue":"16","key":"2887_CR35","doi-asserted-by":"publisher","first-page":"7422","DOI":"10.7150\/thno.42167","volume":"10","author":"CJ Li","year":"2020","unstructured":"Li CJ, Fang QH, Liu ML, Lin JN. Current understanding of the role of adipose-derived extracellular vesicles in metabolic homeostasis and diseases: communication from the distance between cells\/tissues. Theranostics. 2020;10(16):7422\u201335. https:\/\/doi.org\/10.7150\/thno.42167.","journal-title":"Theranostics."},{"issue":"7642","key":"2887_CR36","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature21365","volume":"542","author":"T Thomou","year":"2017","unstructured":"Thomou T, Mori MA, Dreyfuss JM, Konishi M, Sakaguchi M, Wolfrum C, et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature. 2017;542(7642):450\u20135. https:\/\/doi.org\/10.1038\/nature21365.","journal-title":"Nature."},{"issue":"3","key":"2887_CR37","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.7150\/thno.51605","volume":"11","author":"F Prattichizzo","year":"2021","unstructured":"Prattichizzo F, Matacchione G, Giuliani A, Sabbatinelli J, Olivieri F, de Candia P, et al. Extracellular vesicle-shuttled miRNAs: a critical appraisal of their potential as nano-diagnostics and nano-therapeutics in type 2 diabetes mellitus and its cardiovascular complications. Theranostics. 2021;11(3):1031\u201345. https:\/\/doi.org\/10.7150\/thno.51605.","journal-title":"Theranostics."},{"issue":"1","key":"2887_CR38","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12967-020-02398-6","volume":"18","author":"SF Wu","year":"2020","unstructured":"Wu SF, Noren Hooten N, Freeman DW, Mode NA, Zonderman AB, Evans MK. Extracellular vesicles in diabetes mellitus induce alterations in endothelial cell morphology and migration. J Transl Med. 2020;18(1):230. https:\/\/doi.org\/10.1186\/s12967-020-02398-6.","journal-title":"J Transl Med."},{"issue":"1","key":"2887_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41467-020-20500-w","volume":"12","author":"A Kumar","year":"2021","unstructured":"Kumar A, Sundaram K, Mu J, Dryden GW, Sriwastva MK, Lei C, et al. High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance. Nat Commun. 2021;12(1):213. https:\/\/doi.org\/10.1038\/s41467-020-20500-w.","journal-title":"Nat Commun."},{"issue":"8","key":"2887_CR40","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/ncb1752","volume":"10","author":"A Taddei","year":"2008","unstructured":"Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, Pirazzoli V, et al. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol. 2008;10(8):923\u201334. https:\/\/doi.org\/10.1038\/ncb1752.","journal-title":"Nat Cell Biol."},{"key":"2887_CR41","doi-asserted-by":"publisher","unstructured":"Vandenbroucke St Amant E, Tauseef M, Vogel SM, Gao XP, Mehta D, Komarova YA, et al. PKC\u03b1 activation of p120-catenin serine 879 phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity. Circ Res. 2012;111(6):739-49. https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.269654.","DOI":"10.1161\/CIRCRESAHA.112.269654"},{"issue":"3","key":"2887_CR42","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20131190","volume":"211","author":"H Gong","year":"2014","unstructured":"Gong H, Gao X, Feng S, Siddiqui MR, Garcia A, Bonini MG, et al. Evidence of a common mechanism of disassembly of adherens junctions through G\u03b113 targeting of VE-cadherin. J Exp Med. 2014;211(3):579\u201391. https:\/\/doi.org\/10.1084\/jem.20131190.","journal-title":"J Exp Med."},{"issue":"7057","key":"2887_CR43","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nature03952","volume":"437","author":"E Tzima","year":"2005","unstructured":"Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, et al. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature. 2005;437(7057):426\u201331. https:\/\/doi.org\/10.1038\/nature03952.","journal-title":"Nature."},{"issue":"11","key":"2887_CR44","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1091\/mbc.e05-05-0440","volume":"16","author":"K Xiao","year":"2005","unstructured":"Xiao K, Garner J, Buckley KM, Vincent PA, Chiasson CM, Dejana E, et al. p120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin. Mol Biol Cell. 2005;16(11):5141\u201351. https:\/\/doi.org\/10.1091\/mbc.e05-05-0440.","journal-title":"Mol Biol Cell."},{"issue":"7","key":"2887_CR45","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1182\/blood-2008-03-147181","volume":"112","author":"P Alcaide","year":"2008","unstructured":"Alcaide P, Newton G, Auerbach S, Sehrawat S, Mayadas TN, Golan DE, et al. p120-Catenin regulates leukocyte transmigration through an effect on VE-cadherin phosphorylation. Blood. 2008;112(7):2770\u20139. https:\/\/doi.org\/10.1182\/blood-2008-03-147181.","journal-title":"Blood."},{"issue":"6","key":"2887_CR46","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/s1097-2765(00)80221-x","volume":"4","author":"BP Eliceiri","year":"1999","unstructured":"Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell. 1999;4(6):915\u201324. https:\/\/doi.org\/10.1016\/s1097-2765(00)80221-x.","journal-title":"Mol Cell."},{"issue":"7","key":"2887_CR47","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/jpp\/rgaa039","volume":"73","author":"Y Wang","year":"2021","unstructured":"Wang Y, Xue L, Wu Y, Zhang J, Dai Y, Li F, et al. Ruscogenin attenuates sepsis-induced acute lung injury and pulmonary endothelial barrier dysfunction via TLR4\/Src\/p120-catenin\/VE-cadherin signalling pathway. J Pharm Pharmacol. 2021;73(7):893\u2013900. https:\/\/doi.org\/10.1093\/jpp\/rgaa039.","journal-title":"J Pharm Pharmacol."},{"key":"2887_CR48","doi-asserted-by":"publisher","unstructured":"Liu D, Xu H, Zhang C, Xie H, Yang Q, Li W, et al. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF\/VEGFR2\/Src signaling pathway. Life Sci. 2020;259:118273. https:\/\/doi.org\/10.1016\/j.lfs.2020.118273.","DOI":"10.1016\/j.lfs.2020.118273"},{"issue":"7","key":"2887_CR49","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1002\/j.1460-2075.1993.tb05923.x","volume":"12","author":"G Superti-Furga","year":"1993","unstructured":"Superti-Furga G, Fumagalli S, Koegl M, Courtneidge SA, Draetta G. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src. EMBO J. 1993;12(7):2625\u201334. https:\/\/doi.org\/10.1002\/j.1460-2075.1993.tb05923.x.","journal-title":"EMBO J."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02887-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-023-02887-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02887-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T14:02:26Z","timestamp":1685109746000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-023-02887-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2887"],"URL":"https:\/\/doi.org\/10.1186\/s12916-023-02887-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"assertion":[{"value":"20 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental animal procedures were approved by the Animal Care and Use Committee of the Fourth Military Medical University and followed the Animal Research Advisory Committee of the National Institutes of Health guidelines (Approval ID: 20201017).The study was following the Declaration of Helsinki. The studies involving participants were reviewed and approved by the Institutional Review Board of Xijing Hospital (ClinicalTrials.gov, Identifier: NCT04570527).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study was conducted in compliance with the Helsinki Declaration and all participants have provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"197"}}